Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823327 · ClinicalTrials.gov registry record
Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Terminated
- Registry status
- 25
- Enrollment target
NCT02823327: Clinical Trial study, sponsored by AIDS Malignancy Consortium.
NCT02823327 is a clinical trial that was terminated before completion, run by AIDS Malignancy Consortium. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02823327 was terminated before completion, sponsored by AIDS Malignancy Consortium.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This research trial studies clinical factors and gene expression analysis for prognosis in tissue samples from patients with acquired immune deficiency syndrome (AIDS)-related primary effusion lymphoma. Gathering health information over time and studying samples of tissue from patients in the laboratory may help doctors learn about the prognosis of patients with AIDS-related primary effusion lymphoma.
Primary Outcome
The resultant data will be a subset of the whole analysis population due to RNAseq data availability. It will be assessed for quality, normalized, and then analyzed for differential gene expression. The Nanostring software nSolver will be used to do quality control, background subtraction, normalization, and analysis of the differential expression for RNA-sequencing data. Lastly, bioinformatic analysis approaches will be used to help make sense of possible biological links between the genes foun
Interventions
- OTHER Medical Chart Review
- GENETIC Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-10-11 |
| Est. Completion | 2023-02-03 |
Why NCT02823327 stopped before completion
NCT02823327 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT02823327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02823327 about?
NCT02823327 is a clinical study titled "Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma". This research trial studies clinical factors and gene expression analysis for prognosis in tissue samples from patients with acquired immune deficiency syndrome (AIDS)-related primary effusion lymphoma. Gathering health information over time and studying samples of tissue from patients in the labora...
What is the current status of trial NCT02823327?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2016-10-11. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT02823327?
The interventions under investigation include: Medical Chart Review (OTHER), Laboratory Biomarker Analysis (GENETIC).
Who is sponsoring clinical trial NCT02823327?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI